“Combining RNAi with Immune Oncology can improve efficacy of IO drugs in pancreatic cancer” – Silenseed will be presenting on “RNAi in the clinic – phase 2 in pancreatic cancer with/without immune-oncology” in the “2nd Annual RNA Therapeutics Summit” October 19th-20th 2017, Barcelona.

 

2nd-RNA-Therapeutics-agenda_draft-1